Cabot (CBT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
27 Jan, 2026Executive summary
Annual meeting scheduled for March 12, 2026, at 4:00 p.m. ET, to be held virtually via the internet.
Proxy materials and 2025 Annual Report are available online for review and voting.
Shareholders are encouraged to vote electronically and can opt for electronic delivery of future materials.
Voting matters and shareholder proposals
Election of three directors to serve terms expiring in 2029: Sean D. Keohane, Raffiq Nathoo, and Thierry Vanlancker.
Advisory vote to approve executive compensation.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending September 30, 2026.
Board recommends voting FOR all nominees and proposals.
Board of directors and corporate governance
Board of Directors has nominated three individuals for election to the class of directors with terms expiring in 2029.
Latest events from Cabot
- Adjusted EPS down 13% to $1.53; Battery Materials up 39%, Reinforcement Materials EBIT down 22%.CBT
Q1 20264 Feb 2026 - Q3 adjusted EPS up 35% year-over-year; FY2024 guidance raised on strong segment growth.CBT
Q3 20242 Feb 2026 - Virtual meeting to elect directors, approve pay, and ratify auditor, with strong ESG focus.CBT
Proxy Filing27 Jan 2026 - 31% EPS growth, $265M returned to shareholders, and 2025 EPS guidance of $7.40–$7.80.CBT
Q4 202416 Jan 2026 - FY24 adjusted EPS guidance raised to $7.00–$7.10, driven by battery, E2C, and inkjet growth.CBT
Investor Day 202412 Jan 2026 - Adjusted EPS up 13% to $1.76; net income and cash flow drive strong shareholder returns.CBT
Q1 20259 Jan 2026 - Annual meeting to vote on directors, executive pay, new incentive plan, and auditor ratification.CBT
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, incentive plan, and auditor ratification.CBT
Proxy Filing1 Dec 2025 - Q3 FY25 Adjusted EPS was $1.90, with mixed segment results and strong cash flow.CBT
Q3 202523 Nov 2025